ClinicalTrials.gg
CompletedNCT04576442Updated Oct 30, 2026Results posted

Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)

An interventional study of Asthma-PASS and Basic Asthma Management (AM) in Asthma in Children, sponsored by Montefiore Medical Center. Completed at 1 site in United States. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Montefiore Medical Center · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 30, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
452
Allocation
Randomized
Ages
4 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Asthma by Montefiore Medical Center — 3 open to participants now, 3 under way, none of them phase 3. Asthma · Montefiore Medical Center.

Enrollment
2nd of 16
452 · median 171
Started
2021
with 2 others
No phase
14 of 17
2 open now
Registered
12th of 17
by date

Among the 17 studies in Asthma by Montefiore Medical Center, this one is the 2nd largest by enrollment of the 16 interventional ones that give a count, is one of 3 that started in 2021, is one of 14 with no phase, and was the 12th registered.

Asthma

4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.

Browse Asthma studies →

Open to participants now

3 of the 17 studies in Asthma by Montefiore Medical Center are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.

This study: 4 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Asthma by Montefiore Medical Center, or all of them as a file.
02

Study summary

Physical activity (PA) is an important component of asthma management in children. Studies show that PA is associated with decreased severity of asthma symptoms, as well as improved disease control and quality of life. However, urban minority children with asthma face barriers to PA on multiple levels.The goal of this research project is to evaluate whether a multifaceted school-based intervention that addresses key barriers to physical activity reduces asthma morbidity among urban schoolchildren with asthma.

Read the detailed description

Investigators will conduct a cluster-randomized controlled trial with eligible children with persistent or uncontrolled asthma from 60 Bronx schools. Schools will be randomly assigned to either (1) the Asthma-PASS intervention or an asthma management (AM) comparison group. Both groups will participate in an existing classroom-based daily activity program. Enrollment will occur over 4 consecutive school years with 4-8 schools joining the study each year. The investigators will assess the effectiveness of Asthma-PASS in reducing asthma morbidity and improving PA as well as additional clinical and functional outcomes. The investigators will also identify potential mediators and moderators of the intervention effect. They will evaluate the process of intervention implementation by applying the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. The RE-AIM framework is a public health tool used for planning and evaluating programs to improve translation from research into practice and ensure sustainability in real-world settings.

03

Conditions studied

  • Asthma in Children

Browse trials for

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physician-diagnosed asthma (based on parent report with validation from the child's physician)
  • Intermittent asthma (but with a report of asthma symptoms, such as coughing, wheezing, chest tightness, mucus/phlegm or shortness of breath, in the past 12 months)
  • Mild persistent or more severe asthma based on prescribed controller medication (currently well-controlled) but with a report of asthma symptoms (as specified above) within the past 12 months [well-controlled due to taking controller medications in the past 12 months and without asthma symptoms (as specified above) within the past 12 months will qualify]
  • Mild persistent or more severe asthma, or asthma that is uncontrolled despite therapy (based on age-specific guidelines)
  • Attending pre-kindergarten through 5th grade in NYC (primarily Bronx) schools and also schools in lower Hudson Valley
  • Parent is able to speak and understand either English or Spanish
  • Consent from the primary caregiver, caregiver permission for child participation as well as assent from the child (for age 7 and above)

Exclusion criteria

Exclusion Criteria:

  • No access to a phone to conduct follow-up surveys
  • Family plans to leave the school or city in less than 6 months
  • The child has other significant medical conditions, such as congenital heart disease, cystic fibrosis, or other chronic lung disease
  • Child is unable to participate in routine physical education (PE) classes as per physician-completed sports participation form
  • Children in foster care or other situations in which consent cannot be obtained from a guardian
  • Child is a participant in a concurrent asthma intervention study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
452 participants (actual)

Study arms

  • Experimental
    Asthma-PASS Intervention

    Collaboration with PCPs to optimize management. Community Health Worker (CHW) to ensure PCP plan is followed. Two asthma education sessions with children/caregivers focusing on self-efficacy and physical activity promotion. Promotion of asthma awareness in school. School personnel training in asthma

    Behavioral: Asthma-PASS · Behavioral: Child/Caregiver Education session

  • Active comparator
    Asthma Management Comparison Group

    Includes two sessions of basic asthma education and PCP notification of child's asthma severity level.

    Behavioral: Basic Asthma Management (AM) · Behavioral: Child/Caregiver Education session

Interventions

  • BehavioralAsthma-PASS

    The investigator will collaborate with the student's primary care provider (PCP) by sending a letter via facsimile, and/or e-mail to ensure appropriate medications are prescribed or adjusted and rescue medications are available at school. Community Health Workers (CHWs) will follow up with PCPs as needed to provide reminders about prescriptions for controlled medications and to ensure a medication administration form (MAF) is provided to schools to allow rescue medication administration by nurses. CHWs will work with local pharmacies when possible to have prescribed medications delivered to schools and homes. For students without a PCP, families will be referred to one of Montefiore Medical Center's 20 practices throughout the Bronx. For students without medical insurance or who are unable to go to a Montefiore clinic, New York City Department of Education (NYC DOE) physicians who routinely attend NYC schools will provide medical care and prescribe appropriate medications.

  • BehavioralBasic Asthma Management (AM)

    PCPs and caregivers will be notified that children in the AM group have persistent/uncontrolled asthma that warrants use of guideline-based preventative medications.

  • BehavioralChild/Caregiver Education session

    The investigator will provide in-school child asthma education sessions delivered by trained, bilingual (English-Spanish) Community Health Workers (CHWs) using an established manualized protocol from past and current studies designed to improve knowledge and self-efficacy. Each child will receive two 1-on 1, 20-minute developmentally appropriate educational sessions at school 3-4 weeks apart. Sessions will cover: 1) asthma basics, symptoms and triggers; and 2) medications and correct administration technique. Caregivers will be called after each child session to highlight key points reviewed with the child and answer questions.

06

What researchers measure

Primary outcomes

  1. Symptom Free Days (SFDs)

    SFDs will be assessed. Caregivers will report the number of days their child experienced no symptoms of asthma (defined as 24 hours with no coughing, wheezing, chest tightness, or shortness of breath) over the prior 14 day period.

    Time frame: Baseline, 3, 6, 9, and 12 months

Secondary outcomes

  1. Physical Activity

    Physical activity will be assessed by the number of minutes the child engages in either 'Sedentary,' 'Light,' or 'Moderate-Vigorous' physical activity based on measurements taken using the ActiGraph GT3X+ activity monitor, a small, tri-axial micro-electromechanical system (MEMS) based accelerometer. Measurements will be taken over 7 consecutive days at baseline, 3, 6 and 9 months using the activity monitor. Children will wear the monitor on their waist, secured using an elastic belt. The number of minutes the child is in each level of physical activity will be summarized by study arm.

    Time frame: Baseline, 3, 6 and 9 months

  2. Physical Activity - Proportion

    The proportion of children who participate in in-class physical activity (PA) will be summarized by study arm. It is hypothesized that a greater proportion of children in Asthma-PASS will participate in in-class PA.

    Time frame: Baseline, 3, 6 and 9 months

  3. Physical Activity - Step Counts

    Physical activity was also assessed by step count using data obtained from the ActiGraph GT3X+ activity monitor, a small, tri-axial micro-electromechanical system (MEMS) based accelerometer. Measurements will be taken over 7 consecutive days at baseline, 3, 6 and 9 months using the activity monitor. Children will wear the monitor on their waist, secured using an elastic belt. The number of steps the child took is summarized by study arm.

    Time frame: Baseline, 3, 6 and 9 months

Other outcomes

  1. Pediatric Asthma Caregiver's Quality of Life

    Validated caregiver asthma related quality of life survey; 13 items, 7-point scale (ranging from 1-7); higher score indicates less impairment

    Time frame: 3-12 months

  2. Childhood Asthma Control Test

    asthma control based on symptom frequency; score 0-27; higher score indicates well controlled asthma; score 19 or less indicates uncontrolled asthma.

    Time frame: 3-12 months

  3. Adherence

    controller medication adherence, score range 0-4; higher scores corresponding to recommended behavior.

    Time frame: 3-12 months

  4. Asthma Self-management Questionnaire

    caregiver self-management behavior; score range 0-100; higher score indicates more knowledge of self-management

    Time frame: 3-12 months

  5. Asthma Knowledge

    Caregiver asthma knowledge using sub-scale of Asthma Illness Representation Scale; score range 1-5; higher score represent better knowledge.

    Time frame: 3-12 months

07

Results

Posted Oct 30, 2026

Participant flow

Children were subjects in the study. Caregivers had to complete validated surveys in order to collect child-specific outcome measures about their child's asthma. The study was exclusively for children with asthma. Caregivers were not subjects in the study.

Participant flow — Overall Study
MilestoneAsthma-PASS InterventionAsthma Management Comparison Group
Started226226
Completed204208
Not completed2218
Withdrew: Withdrawal by subject1211
Withdrew: Lost to follow-up107

Outcome measures

PrimarySymptom Free Days (SFDs)

SFDs will be assessed. Caregivers will report the number of days their child experienced no symptoms of asthma (defined as 24 hours with no coughing, wheezing, chest tightness, or shortness of breath) over the prior 14 day period.

Time frame:
Baseline, 3, 6, 9, and 12 months
Reported as:
Mean · days
Symptom Free Days (SFDs)
daysAsthma-PASS InterventionAsthma Management Comparison Group
Baseline7.57 ± 4.957.97 ± 4.84
3 month10.69 ± 3.9310.56 ± 4.23
6 month10.98 ± 3.9510.96 ± 4.05
9 month11.79 ± 3.4211.46 ± 3.76
12 month11.50 ± 3.8210.58 ± 4.19
Statistical analysis
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.293 · Ratio of rate ratios: 1.07 · 95% CI 0.95 to 1.20
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.395 · Ratio of rate ratios: 1.05 · 95% CI 0.93 to 1.19
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.178 · Ratio of rate ratios: 1.08 · 95% CI 0.96 to 1.22
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.042 · Ratio of rate ratios: 1.14 · 95% CI 1.01 to 1.20
SecondaryPhysical Activity

Physical activity will be assessed by the number of minutes the child engages in either 'Sedentary,' 'Light,' or 'Moderate-Vigorous' physical activity based on measurements taken using the ActiGraph GT3X+ activity monitor, a small, tri-axial micro-electromechanical system (MEMS) based accelerometer. Measurements will be taken over 7 consecutive days at baseline, 3, 6 and 9 months using the activity monitor. Children will wear the monitor on their waist, secured using an elastic belt. The number of minutes the child is in each level of physical activity will be summarized by study arm.

Time frame:
Baseline, 3, 6 and 9 months
Reported as:
Mean · minutes
Physical Activity
minutesAsthma-PASS InterventionAsthma Management Comparison Group
Light - Baseline218.83 ± 54.83222.80 ± 54.29
Light - 3 months161.64 ± 86.03163.06 ± 90.15
Light - 6 months159.49 ± 88.09174.37 ± 92.41
Light - 9 months149.40 ± 86.99153.77 ± 90.37
Moderate-Vigorous Baseline48.71 ± 26.9748.94 ± 20.51
Moderate-Vigorous 3 months54.57 ± 24.6256.49 ± 27.13
Moderate-Vigorous 6 months57.65 ± 25.0655.26 ± 24.10
Moderate-Vigorous 9 months53.51 ± 25.2853.61 ± 15.87
Sedentary - Baseline469.03 ± 94.44460.45 ± 100.42
Sedentary - 3 months539.17 ± 118.47527.99 ± 129.62
Sedentary - 6 months527.71 ± 112.67529.10 ± 129.43
Sedentary - 9 months539.09 ± 124.25523.99 ± 132.45
Statistical analysis
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.691 · Difference of difference: -1.70 · 95% CI -10.10 to 6.69
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.543 · Difference of difference: 2.62 · 95% CI -5.82 to 11.07
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.978 · Difference of difference: 0.13 · 95% CI -8.67 to 8.92
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.835 · Difference of difference: 2.55 · 95% CI -21.45 to 26.54
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.410 · Difference of difference: -10.91 · 95% CI -36.89 to 15.06
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.976 · Difference of difference: -0.40 · 95% CI -26.71 to 25.90
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.888 · Difference of difference: 2.59 · 95% CI -33.41 to 38.59
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.601 · Difference of difference: -9.98 · 95% CI -47.35 to 27.40
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.738 · Difference of difference: 6.52 · 95% CI -31.63 to 44.67
Other pre-specifiedPediatric Asthma Caregiver's Quality of Life

Validated caregiver asthma related quality of life survey; 13 items, 7-point scale (ranging from 1-7); higher score indicates less impairment

Time frame:
3-12 months

Results for this outcome have not been posted.

Other pre-specifiedChildhood Asthma Control Test

asthma control based on symptom frequency; score 0-27; higher score indicates well controlled asthma; score 19 or less indicates uncontrolled asthma.

Time frame:
3-12 months

Results for this outcome have not been posted.

Other pre-specifiedAdherence

controller medication adherence, score range 0-4; higher scores corresponding to recommended behavior.

Time frame:
3-12 months

Results for this outcome have not been posted.

Other pre-specifiedAsthma Self-management Questionnaire

caregiver self-management behavior; score range 0-100; higher score indicates more knowledge of self-management

Time frame:
3-12 months

Results for this outcome have not been posted.

Other pre-specifiedAsthma Knowledge

Caregiver asthma knowledge using sub-scale of Asthma Illness Representation Scale; score range 1-5; higher score represent better knowledge.

Time frame:
3-12 months

Results for this outcome have not been posted.

SecondaryPhysical Activity - Proportion

The proportion of children who participate in in-class physical activity (PA) will be summarized by study arm. It is hypothesized that a greater proportion of children in Asthma-PASS will participate in in-class PA.

Time frame:
Baseline, 3, 6 and 9 months

No measurements were reported for this outcome.

SecondaryPhysical Activity - Step Counts

Physical activity was also assessed by step count using data obtained from the ActiGraph GT3X+ activity monitor, a small, tri-axial micro-electromechanical system (MEMS) based accelerometer. Measurements will be taken over 7 consecutive days at baseline, 3, 6 and 9 months using the activity monitor. Children will wear the monitor on their waist, secured using an elastic belt. The number of steps the child took is summarized by study arm.

Time frame:
Baseline, 3, 6 and 9 months
Reported as:
Mean · number of steps
Physical Activity - Step Counts
number of stepsAsthma-PASS InterventionAsthma Management Comparison Group
Baseline7168.86 ± 1959.377335.13 ± 2430.19
3 months7318.86 ± 2393.757268.40 ± 2361.19
6 months7748.53 ± 2515.247747.63 ± 2612.81
9 months7084.17 ± 2388.917089.02 ± 2308.95
Statistical analysis
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.564 · Difference of difference: 216.73 · 95% CI -519.69 to 953.15
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.665 · Difference of difference: 167.18 · 95% CI -589.83 to 924.19
  • Asthma-PASS Intervention vs Asthma Management Comparison Group · GLM with GEE · p = 0.682 · Difference of difference: 161.43 · 95% CI -610.16 to 933.02

Adverse events

Collected over 1 year. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Asthma-PASS Intervention0/226 (0%)10/226 (4.4%)63/226 (27.9%)
Asthma Management Comparison Group0/226 (0%)7/226 (3.1%)29/226 (12.8%)
Most frequent serious events
Most frequent serious events
EventAsthma-PASS InterventionAsthma Management Comparison Group
Hospitalization for asthma or respiratory symptomsRespiratory, thoracic and mediastinal disorders10/2267/226
Most frequent other events
Most frequent other events
EventAsthma-PASS InterventionAsthma Management Comparison Group
asthma-related symptomsRespiratory, thoracic and mediastinal disorders52/22625/226
Viral or other infectionsInfections and infestations14/2264/226

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Asthma-PASS InterventionAsthma Management Comparison GroupTotal
<=18 years226226452
Between 18 and 65 years000
>=65 years000
Age, Continuous
Age, Continuous(years)Asthma-PASS InterventionAsthma Management Comparison GroupTotal
Mean8.09 ± 1.857.91 ± 1.958.00 ± 1.90
Sex: Female, Male
Sex: Female, Male(Participants)Asthma-PASS InterventionAsthma Management Comparison GroupTotal
Female93105198
Male133121254
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Asthma-PASS InterventionAsthma Management Comparison GroupTotal
Hispanic or Latino167172339
Not Hispanic or Latino5953112
Unknown or Not Reported011
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Asthma-PASS InterventionAsthma Management Comparison GroupTotal
American Indian or Alaska Native134
Asian6410
Native Hawaiian or Other Pacific Islander000
Black or African American7770147
White81725
More than one race182139
Unknown or Not Reported116111227
Region of Enrollment
Region of Enrollment(participants)Asthma-PASS InterventionAsthma Management Comparison GroupTotal
United States226226452
08

Study locations

1 site
  • Children's Hospital at Montefiore, Albert Einstein College of Medicine
    The Bronx, New York 10467, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2021 to primary completion in Aug 2025, 54 months.

Results were first posted in Oct 2026, 1 year 2 months after primary completion. A results delay was requested in Aug 2026.

Of 601 non-industry interventional studies with no phase under Asthma, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's 54 months is above that.

Counting every sponsor, half of 651 studies reached it within 23 months; a quarter within 10 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2020
First posted
Oct 6, 2020
StartActual
Feb 9, 2021
Primary completionActual
Aug 27, 2025
CompletionActual
Aug 27, 2025
Results delay requested
Aug 25, 2026
Results first posted
Oct 30, 2026
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 30, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange in the number of Symptom free daysFree Days (SFDs)Time frame: Baseline, 3, 6, 9, and 12 months
Oct 30, 2026
Documents
Secondary outcomes
3 edited, 2 added
What changed in the outcomes
  • EditedPhysical activityActivityTime frame: Baseline, 3, 6 and 9 months
  • AddedPhysical Activity - ProportionTime frame: Baseline, 3, 6 and 9 months
  • AddedPhysical Activity - Step CountsTime frame: Baseline, 3, 6 and 9 months
  • Editedother outcomeAsthma selfSelf-management questionnaireQuestionnaireTime frame: 3-12 months
  • Editedother outcomeAsthma knowledgeKnowledgeTime frame: 3-12 months
Oct 30, 2026
Show all 2 updates
  1. Oct 30, 2026
    Results posted
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange in the number of Symptom free daysFree Days (SFDs)Time frame: Baseline, 3, 6, 9, and 12 months
    Secondary outcomes 3 edited, 2 added
    What changed in the outcomes
    • EditedPhysical activityActivityTime frame: Baseline, 3, 6 and 9 months
    • AddedPhysical Activity - ProportionTime frame: Baseline, 3, 6 and 9 months
    • AddedPhysical Activity - Step CountsTime frame: Baseline, 3, 6 and 9 months
    • Editedother outcomeAsthma selfSelf-management questionnaireQuestionnaireTime frame: 3-12 months
    • Editedother outcomeAsthma knowledgeKnowledgeTime frame: 3-12 months
    + 1 other change: verification date
  2. Sep 25, 2026
    Minor edits only
    + 4 other changes: identifiers, verification date, registry dates and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04576442
Responsible party
Sponsor
First posted
Oct 6, 2020
Start date
Feb 9, 2021
Primary completion
Aug 27, 2025
Completion
Aug 27, 2025
Results posted
Oct 30, 2026
Last update
Oct 30, 2026

Study contacts

Marina Reznik, MD, MS
principal investigator · Montefiore Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion